Acute kidney injury: Current perspectives

Devasmita Choudhury

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Acute kidney injury (AKI) increases morbidity and mortality, particularly for the critically ill. Recent definitions standardizing AKI to reflect graded changes in serum creatinine and urine output (per the Risk, Injury, Failure, Loss, and End-stage renal failure [RIFLE] and Acute Kidney Injury Network [AKIN] criteria) with severity of renal injury and developments in AKI pathobiology are being utilized to identify biomarkers of early kidney injury. These developments may be useful in the early intervention of preventing AKI. Although there has been progress in the management of AKI, therapeutic challenges include appropriate prophylaxis prior to contrast administration, use of diuretics, vasopressors, and the type and dose of renal replacement therapy. Future use of bioartificial dialyzers, plasma therapies, and the possibility of stem cell regeneration of injured kidney tissue are being actively investigated to provide alternative treatment options for AKI. This RE aims to provide an overview of current practices, available therapies, and continued research in AKI therapy.

Original languageEnglish (US)
Pages (from-to)29-40
Number of pages12
JournalPostgraduate Medicine
Volume122
Issue number6
DOIs
StatePublished - Nov 2010

Fingerprint

Acute Kidney Injury
Kidney
Wounds and Injuries
Therapeutics
Renal Replacement Therapy
Diuretics
Critical Illness
Chronic Kidney Failure
Regeneration
Creatinine
Stem Cells
Biomarkers
Urine
Morbidity
Mortality
Serum
Research

Keywords

  • Acute kidney injury
  • Comorbidities
  • Critically ill
  • Kidney failure
  • Renal failure

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Acute kidney injury : Current perspectives. / Choudhury, Devasmita.

In: Postgraduate Medicine, Vol. 122, No. 6, 11.2010, p. 29-40.

Research output: Contribution to journalArticle

Choudhury, Devasmita. / Acute kidney injury : Current perspectives. In: Postgraduate Medicine. 2010 ; Vol. 122, No. 6. pp. 29-40.
@article{321cd8b8235c4ecbae06149b29aa06b7,
title = "Acute kidney injury: Current perspectives",
abstract = "Acute kidney injury (AKI) increases morbidity and mortality, particularly for the critically ill. Recent definitions standardizing AKI to reflect graded changes in serum creatinine and urine output (per the Risk, Injury, Failure, Loss, and End-stage renal failure [RIFLE] and Acute Kidney Injury Network [AKIN] criteria) with severity of renal injury and developments in AKI pathobiology are being utilized to identify biomarkers of early kidney injury. These developments may be useful in the early intervention of preventing AKI. Although there has been progress in the management of AKI, therapeutic challenges include appropriate prophylaxis prior to contrast administration, use of diuretics, vasopressors, and the type and dose of renal replacement therapy. Future use of bioartificial dialyzers, plasma therapies, and the possibility of stem cell regeneration of injured kidney tissue are being actively investigated to provide alternative treatment options for AKI. This RE aims to provide an overview of current practices, available therapies, and continued research in AKI therapy.",
keywords = "Acute kidney injury, Comorbidities, Critically ill, Kidney failure, Renal failure",
author = "Devasmita Choudhury",
year = "2010",
month = "11",
doi = "10.3810/pgm.2010.11.2220",
language = "English (US)",
volume = "122",
pages = "29--40",
journal = "Postgraduate Medicine",
issn = "0032-5481",
publisher = "Medquest Communications LLC",
number = "6",

}

TY - JOUR

T1 - Acute kidney injury

T2 - Current perspectives

AU - Choudhury, Devasmita

PY - 2010/11

Y1 - 2010/11

N2 - Acute kidney injury (AKI) increases morbidity and mortality, particularly for the critically ill. Recent definitions standardizing AKI to reflect graded changes in serum creatinine and urine output (per the Risk, Injury, Failure, Loss, and End-stage renal failure [RIFLE] and Acute Kidney Injury Network [AKIN] criteria) with severity of renal injury and developments in AKI pathobiology are being utilized to identify biomarkers of early kidney injury. These developments may be useful in the early intervention of preventing AKI. Although there has been progress in the management of AKI, therapeutic challenges include appropriate prophylaxis prior to contrast administration, use of diuretics, vasopressors, and the type and dose of renal replacement therapy. Future use of bioartificial dialyzers, plasma therapies, and the possibility of stem cell regeneration of injured kidney tissue are being actively investigated to provide alternative treatment options for AKI. This RE aims to provide an overview of current practices, available therapies, and continued research in AKI therapy.

AB - Acute kidney injury (AKI) increases morbidity and mortality, particularly for the critically ill. Recent definitions standardizing AKI to reflect graded changes in serum creatinine and urine output (per the Risk, Injury, Failure, Loss, and End-stage renal failure [RIFLE] and Acute Kidney Injury Network [AKIN] criteria) with severity of renal injury and developments in AKI pathobiology are being utilized to identify biomarkers of early kidney injury. These developments may be useful in the early intervention of preventing AKI. Although there has been progress in the management of AKI, therapeutic challenges include appropriate prophylaxis prior to contrast administration, use of diuretics, vasopressors, and the type and dose of renal replacement therapy. Future use of bioartificial dialyzers, plasma therapies, and the possibility of stem cell regeneration of injured kidney tissue are being actively investigated to provide alternative treatment options for AKI. This RE aims to provide an overview of current practices, available therapies, and continued research in AKI therapy.

KW - Acute kidney injury

KW - Comorbidities

KW - Critically ill

KW - Kidney failure

KW - Renal failure

UR - http://www.scopus.com/inward/record.url?scp=79952201095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952201095&partnerID=8YFLogxK

U2 - 10.3810/pgm.2010.11.2220

DO - 10.3810/pgm.2010.11.2220

M3 - Article

C2 - 21084779

AN - SCOPUS:79952201095

VL - 122

SP - 29

EP - 40

JO - Postgraduate Medicine

JF - Postgraduate Medicine

SN - 0032-5481

IS - 6

ER -